Try GOLD - Free
Does US cancer drug nod make Cipla attractive?
Mint Chennai
|April 18, 2025
Cipla, which makes HIV, respiratory and cancer drugs, is targeting North America with generic launches
Cipla Ltd's shares have surged 6% since last week when it announced the final approval from the US Food and Drug Administration for its generic version of Bristol Myers Squibb's Abraxane, a cancer drug. Does the approval to sell the much-awaited product in the US make Cipla a compelling buy, especially when Trump's tariffs loom?
"One product approval by itself doesn't suddenly make a company more attractive," said Prashant Nair, lead analyst for pharma and healthcare at Ambit Capital. "Earlier-than-expected approval for Abraxane is positive, but tariffs will have a bearing on Cipla."
This story is from the April 18, 2025 edition of Mint Chennai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 9,500+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Chennai
Mint Chennai
It's Clear That Gamblers Should Pay More Taxes Than Investors
Investing aids the economy but gambling is simply consumption
3 mins
September 15, 2025
Mint Chennai
Finding inspiration in natural light
Nicobar's Simran Lal on how her two workspaces keep her calm, motivated
2 mins
September 15, 2025
Mint Chennai
Yuan versus the dollar: Propose a third option
As China attempts to globalize its legal tender; America guards the supremacy of its own and digital currencies gain traction, India should revive Keynes' idea of a global trade currency
2 mins
September 15, 2025
Mint Chennai
Mercedes Expects Best Festive Season
The recent GST rate cut is likely to make the upcoming festive season the 'best-ever' for the luxury carmaker, but there is a need to cap road taxes levied by states on car purchases for long-term growth of the industry, Mercedes-Benz India managing director and chief executive officer Santosh Iyer said.
1 min
September 15, 2025
Mint Chennai
Indian Market Resilient; Stocks Could Touch New Highs by March
Over the long term, say 7 to 10 years, small and midcaps will be the real winners A. Balasubramanian, managing director and chief executive of Aditya Birla Sun Life AMC
4 mins
September 15, 2025
Mint Chennai
Top Debtor States Seek More From Finance Commission
Greater fiscal relief, revamped criteria for tax revenue sharing, special funds among demands
2 mins
September 15, 2025
Mint Chennai
Insurance law revision likely next session: FM
The Insurance Amendment Bill, which proposes 100% foreign direct investment in the sector, is likely to be introduced in parliament in the winter session, finance minister Nirmala Sitharaman has said.
1 min
September 15, 2025
Mint Chennai
When street dogs, cats bring the office closer
When colleagues work towards a collective goal like looking after community animals, it offers them a sense of purpose
4 mins
September 15, 2025
Mint Chennai
COP-30: Use carbon trading to win climate leadership
An efficient and credible carbon market can give India a chance to lead a global agenda that's fair to everyone
3 mins
September 15, 2025
Mint Chennai
Small stores, bold ambitions: Ikea to ramp up presence
Ikea India plans to add 3-4 small city stores over 10 months, shifting focus from large-format outlets to compact spaces
1 mins
September 15, 2025
Listen
Translate
Change font size